None
Quote | Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX)
Last: | $44.20 |
---|---|
Change Percent: | 0.15% |
Open: | $45.47 |
Close: | $44.20 |
High: | $45.8 |
Low: | $44.13 |
Volume: | 334,607 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX)
2024-06-25 22:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-21 17:40:12 ET Read the full article on Seeking Alpha For further details see: Crinetics Pharmaceuticals files for mixed shelf, to sell shares for holders
Message Board Posts | Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Crinetics Pharmaceuticals Inc. Company Name:
CRNX Stock Symbol:
NASDAQ Market:
Crinetics Pharmaceuticals Inc. Website:
2024-06-25 22:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) today announced that Scott Struthers, Ph.D., founder and chief executive officer of Crinetics, was named an Entrepreneur Of The Year ® 2024 Pacific Southwest Award winner. Entrepreneur Of The Year is the preeminen...
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 158,000 shares of its com...